Home / Community / News / News

News

09/06/2018 - 6:16am

Close monitoring of respiratory function reduces respiratory complications in DM1.

08/09/2018 - 5:07pm

One of the challenges faced by doctors treating patients with myotonic dystrophy type 1 (DM1)—and drug developers designing clinical trials—is the broad difference in the way the disease manifests itself and progresses from patient to patient. MDF Scientific Advisory Committee member Dr. Guillaume Bassez, a neurologist at the Institut de Myologie in Paris, has identified subgroups of the DM population to help address this issue.

07/17/2018 - 8:45am

The OPTIMISTIC clinical evaluation of exercise training and cognitive behavioral therapy paradigms comes to publication.

07/17/2018 - 8:44am

Feasibility is demonstrated in mammalian models for a therapeutic strategy that increases MBNL by sequestering MBNL-suppressive miRs.

06/12/2018 - 8:11am

Insights on the mechanisms that underlie muscle atrophy in DM are provided by studies in a new mouse model.

Partners

ExpansionTherapeutics.png

© Myotonic Dystrophy Foundation. All rights reserved.